Niagen Bioscience Launches Pharmaceutical-Grade Niagen IV in 600 Clinics Nationwide
May 5, 2025
Outperforming NAD+ IV, Niagen IV (patented nicotinamide riboside or NR) provides superior tolerability, a 75% shorter infusion time, and increases NAD+ 20% higher three hours